XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Repurchase Program
Common Stock
Additional Paid-in Capital
Repurchase Program
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Repurchase Program
Total
Balance, beginning of period at Dec. 31, 2020   $ 12   $ 265,478   $ 13,765 $ 2,354     $ 281,609
Balance, beginning of period (in shares) at Dec. 31, 2020   118,854,249                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)           (62,348)       (62,348)
Foreign currency translation adjustments             (1,984)     (1,984)
Dividend to Class A unitholders       (110,033)           (110,033)
Issuance of restricted stock in connection with the Reorganization   $ 1   (1)            
Issuance of restricted stock in connection with the Reorganization (in shares)   8,340,126                
Issuance of common stock upon conversion of Class B units   4,145,987                
Sale of common stock   $ 2   399,262           399,264
Sale of common stock (in shares)   23,000,000                
Repurchase and retirement of common stock   $ (3)   (281,635)           (281,638)
Repurchase and retirement of common stock (in shares)   (33,931,091)                
Retirement of restricted stock (in shares)   (1,014,976)                
Issuance of common stock upon release of restricted stock units (in shares)   51,316                
Stock-based compensation expense       128,775           128,775
Balance, end of period at Dec. 31, 2021   $ 12   401,846   (48,583) 370     353,645
Balance, end of period (in shares) at Dec. 31, 2021   119,445,611                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)           (5,694)       (5,694)
Foreign currency translation adjustments             (3,903)     (3,903)
Sale of common stock   $ 1   269,099           269,100
Sale of common stock (in shares)   13,800,000                
Repurchase and retirement of common stock $ (1) $ (1) $ (23,037) (257,662)         $ (23,038) (257,663)
Repurchase and retirement of common stock (in shares) (4,483,620) (13,800,244)                
Retirement of restricted stock (in shares)   (480,385)                
Issuance of common stock upon release of restricted stock units (in shares)   186,613                
Stock-based compensation expense       50,634           50,634
Balance, end of period at Dec. 31, 2022   $ 11   440,880 $ (291) (54,568) (3,533) $ (291)   382,790
Balance, end of period (in shares) at Dec. 31, 2022   114,667,975                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)           (2,388)       (2,388)
Foreign currency translation adjustments             (6)     (6)
Repurchase and retirement of common stock (in shares) 0                  
Retirement of restricted stock (in shares)   (155,450)                
Issuance of common stock upon release of restricted stock units (in shares)   359,257                
Stock-based compensation expense       18,804           18,804
Balance, end of period at Dec. 31, 2023   $ 11   $ 459,684   $ (56,956) $ (3,539)     $ 399,200
Balance, end of period (in shares) at Dec. 31, 2023   114,871,782